3.2000
-0.1100
(-3.32%)
At close: January 10 at 4:00:01 PM EST
3.3000
+0.10
+(3.12%)
After hours: 7:56:55 PM EST
Key Executives
Key Executives Information Not Available
Neuphoria Therapeutics Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Neuphoria Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 13, 2025 at 10:59 AM UTC - March 17, 2025 at 12:00 PM UTC
Neuphoria Therapeutics Inc. Earnings Date
Recent Events
Related Tickers
SLXN Silexion Therapeutics Corp
1.9400
0.00%
RADX Radiopharm Theranostics Limited
5.35
+30.17%
TCBP TC Biopharm (Holdings) Plc
0.4005
-1.11%
ATNF 180 Life Sciences Corp.
1.5100
0.00%
COEP Coeptis Therapeutics Holdings, Inc.
7.57
+8.30%
PHIO Phio Pharmaceuticals Corp.
1.6900
0.00%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4199
+1.21%
ABVC ABVC BioPharma, Inc.
0.5540
+3.75%
IPSC Century Therapeutics, Inc.
0.9900
-7.48%